Respironics (RESP) 8-K Respironics Reports Record Financial Results for Fiscal Year 2005 First Quarter

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 21, 2004

RESPIRONICS, INC.

(Exact name of Registrant as specified in its charter)

Delaware	000-16723	25-1304989
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)
1010 Murry Ridge Lane Murrysville, Pennsylvania		15668-8525
(Address of Principal Executive Offices)		(Zip Code)

724-387-5200

(Registrant’s telephone number, including area code)

TABLE OF CONTENTS

	Page
Item 2.02. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION		2
SIGNATURES		3
INDEX TO EXHIBITS		4

Item 2.02. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

     On October 21, 2004, Respironics Inc. issued a press release announcing its financial results for the three months ended September 30, 2004. A copy of the press release is attached hereto as Exhibit 99.

Exhibits

     99      Press release, dated October 21, 2004, issued by Respironics, Inc.

2

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

RESPIRONICS, INC.
By:	/s/ Daniel J. Bevevino Daniel J. Bevevino Vice President, and Chief Financial and Principal Accounting Officer

Dated: October 21, 2004

3

INDEX TO EXHIBITS

Exhibit No.	Description
99	Press release, dated October 21, 2004, issued by Respironics, Inc.

4